1-3 of 3
Pier Mannuccio Mannucci
Close
Sort by
Journal Articles

Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination

Carla Valsecchi, Roberta Gualtierotti, Sara Arcudi, Alessandro Ciavarella, Lucia Schiavone, Cristina Novembrino, Simona Maria Siboni, Pier Mannuccio Mannucci, Flora Peyvandi
Journal: Blood Advances
Blood Adv (2023) 7 (1): 174–177.
https://doi.org/10.1182/bloodadvances.2022008989
Published: 2023
Journal Articles

Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

Luciano Baronciani, Ian Peake, Reinhard Schneppenheim, Anne Goodeve, Minoo Ahmadinejad, Zahra Badiee, Mohammad-Reza Baghaipour, Olga Benitez, Imre Bodó, Ulrich Budde, Andrea Cairo, Giancarlo Castaman, Peyman Eshghi, Jenny Goudemand, Wolf Hassenpflug, Hamid Hoorfar, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W. G. Leebeek, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, Renato Marino, Nikolas Nikšić, Florian Oyen, Cristina Santoro, Andreas Tiede, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Eva M. K. Zetterberg, Jeroen Eikenboom, Augusto B. Federici, Flora Peyvandi
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2987–3001.
https://doi.org/10.1182/bloodadvances.2020003397
Published: 2021
Includes: Supplemental data
Journal Articles

New therapies for von Willebrand disease

Pier Mannuccio Mannucci
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3481–3487.
https://doi.org/10.1182/bloodadvances.2019000368
Published: 2019